DK1583967T3 - Fremgangsmåde til inhibering af replikationen af herpesvira - Google Patents
Fremgangsmåde til inhibering af replikationen af herpesviraInfo
- Publication number
- DK1583967T3 DK1583967T3 DK03795968T DK03795968T DK1583967T3 DK 1583967 T3 DK1583967 T3 DK 1583967T3 DK 03795968 T DK03795968 T DK 03795968T DK 03795968 T DK03795968 T DK 03795968T DK 1583967 T3 DK1583967 T3 DK 1583967T3
- Authority
- DK
- Denmark
- Prior art keywords
- replication
- inhibiting
- herpes viruses
- herpesviruses
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10300109A DE10300109A1 (de) | 2003-01-07 | 2003-01-07 | Methode zur Inhibition der Replikation von Herpesviren |
PCT/EP2003/014883 WO2004060860A2 (de) | 2003-01-07 | 2003-12-24 | Verfahren zur inhibierung der replikation von herpesviren |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1583967T3 true DK1583967T3 (da) | 2007-08-06 |
Family
ID=32519615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03795968T DK1583967T3 (da) | 2003-01-07 | 2003-12-24 | Fremgangsmåde til inhibering af replikationen af herpesvira |
Country Status (9)
Country | Link |
---|---|
US (1) | US20070004735A1 (da) |
EP (1) | EP1583967B1 (da) |
AT (1) | ATE365920T1 (da) |
AU (1) | AU2003298244A1 (da) |
DE (2) | DE10300109A1 (da) |
DK (1) | DK1583967T3 (da) |
ES (1) | ES2286499T3 (da) |
PT (1) | PT1583967E (da) |
WO (1) | WO2004060860A2 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3440063B1 (en) | 2016-04-06 | 2020-08-05 | Innovative Molecules GmbH | Aminothiazole derivatives useful as antiviral agents |
CN111433203B (zh) | 2017-10-05 | 2024-02-13 | 创新分子股份有限公司 | 作为抗病毒化合物的取代噻唑的对映异构体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU659861B2 (en) * | 1991-09-10 | 1995-06-01 | Sansho Seiyaku Co., Ltd. | Preparation for promoting hair growth |
US6054472A (en) * | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
CA2223032A1 (en) * | 1997-02-21 | 1998-08-21 | Smithkline Beecham Corporation | Use of hsv-1 ul-15 and vp5 in identifying anti-viral agents |
AU5556799A (en) * | 1998-08-12 | 2000-03-06 | University Of Virginia Patent Foundation | Assay for assembly of herpes simplex virus capsid |
US20010007877A1 (en) * | 1998-12-16 | 2001-07-12 | George O. Burton | Novel anti-infectives |
DE10148598A1 (de) * | 2001-04-19 | 2002-10-24 | Bayer Ag | Neue Arylsulfonamide als antivirale Mittel |
DE10131133A1 (de) * | 2001-06-28 | 2003-01-16 | Bayer Ag | Pyridazinone |
DE10222024A1 (de) * | 2002-05-17 | 2003-11-27 | Bayer Ag | Lactame |
-
2003
- 2003-01-07 DE DE10300109A patent/DE10300109A1/de not_active Ceased
- 2003-12-24 DK DK03795968T patent/DK1583967T3/da active
- 2003-12-24 PT PT03795968T patent/PT1583967E/pt unknown
- 2003-12-24 WO PCT/EP2003/014883 patent/WO2004060860A2/de active IP Right Grant
- 2003-12-24 AU AU2003298244A patent/AU2003298244A1/en not_active Abandoned
- 2003-12-24 AT AT03795968T patent/ATE365920T1/de not_active IP Right Cessation
- 2003-12-24 US US10/541,886 patent/US20070004735A1/en not_active Abandoned
- 2003-12-24 EP EP03795968A patent/EP1583967B1/de not_active Expired - Lifetime
- 2003-12-24 ES ES03795968T patent/ES2286499T3/es not_active Expired - Lifetime
- 2003-12-24 DE DE50307587T patent/DE50307587D1/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2003298244A1 (en) | 2004-07-29 |
DE50307587D1 (de) | 2007-08-09 |
DE10300109A1 (de) | 2004-07-15 |
EP1583967B1 (de) | 2007-06-27 |
ATE365920T1 (de) | 2007-07-15 |
EP1583967A2 (de) | 2005-10-12 |
ES2286499T3 (es) | 2007-12-01 |
AU2003298244A8 (en) | 2004-07-29 |
WO2004060860A3 (de) | 2005-02-10 |
WO2004060860A2 (de) | 2004-07-22 |
US20070004735A1 (en) | 2007-01-04 |
PT1583967E (pt) | 2007-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1716162T3 (da) | Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme | |
BRPI0410870A (pt) | compostos trieterocìclicos, composições, e métodos para tratar cáncer ou doenças virais | |
NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
BRPI0411900B8 (pt) | compostos e composições farmacêuticas compreendendo os mesmos | |
BRPI0507628A (pt) | composto ou sal farmaceuticamente aceitável do mesmo, método de tratamento de uma infecção viral em um ser humano, uso de um composto composição farmacêutica, e, processo para a preparação de um composto | |
CR8778A (es) | Revestimientos de azucar y metodos para estos | |
WO2008127364A3 (en) | Antiviral compounds and use thereof | |
DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
WO2004085479A3 (en) | Treatment of viral infections | |
MY140826A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments. | |
BRPI0516483A (pt) | preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade | |
EA201200631A1 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
NO20070751L (no) | Inhibitorer av HCV-replifikasjon | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
BRPI0513513A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente | |
BRPI0514133A (pt) | compostos de fórmula i, processo para a sua fabricação, composições farmacêuticas, método para o tratamento e/ou profilaxia de doença que são mediadas por inibidores de cetp e uso dos compostos de fórmula i | |
TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
BRPI0412999A (pt) | 2-aminotetralina substituìda para tratamento de depressão | |
BRPI0416287A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização | |
RS51069B (sr) | Upotreba oksikodona za tretiranje visceralnog bola | |
MX2009011512A (es) | Nuevos compuestos peptidos ciclicos. | |
NO20091955L (no) | Antivirale sammensetninger, og fremgangsmater for anvendelse | |
DK1853232T3 (da) | Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse | |
WO2005041951A3 (en) | Rhodanine derivatives for use as antiviral agents |